SMITH: Small steps, big results: gauging design’s impact
Metrics make a difference in health care facilities.
Metrics make a difference in health care facilities.
Alex Slabosky, who ran the M-Plan HMO for 20 years, is retiring from IU Health and has been replaced by the hospital’s treasurer, Ryan Kitchell.
UnitedHealth Group Inc. said it will acquire XLHealth Corp., a provider of managed care for chronically ill Medicare members. Indianapolis-based WellPoint Inc. had been considering a possible acquisition of the company.
Few employers in Indiana say they’re likely to drop health benefits after state insurance exchanges are formed in 2014, according to a new survey by the health benefits firm Mercer.
Eli Lilly and Co.’s experimental drug doubled levels of good cholesterol in a study, setting up a race with Merck & Co. and Roche Holding AG to develop a new class of medicines to lower heart risk.
The Indianapolis-based company is searching for a buyer for its once-promising DailyMed pharmacy service as it struggles to pay $30 million in debt that comes due in April.
The Supreme Court said Monday it will hear arguments next March over President Barack Obama's health care overhaul — a case that could shake the political landscape just as voters are deciding if Obama deserves another term.
A study showing Johnson & Johnson and Bayer AG’s blood-thinner Xarelto succeeded where rival drugs failed could give the companies entry to a $1 billion-plus market where Eli Lilly already competes.
Terre Haute’s Union Hospital is investing $100,000 in Marian University’s new College of Osteopathic Medicine.
XL Health specializes in chronically ill Medicare members, could help WellPoint profits as baby boomers age.
Dr. Jeff Sperring takes the helm after a leadership void created by the departure of Riley’s CEO and COO in late spring.
The Indianapolis-based pharmaceutical firm claims an Australian veterinary clinic is infringing on its Comfortis flea medication’s trademark by reselling it to U.S. consumers online.
A new study says biomedical research at the Indiana University School of Medicine and its partner hospitals pumped about $370 million into Indiana's economy in 2009.
WellPoint is among 11 insurers ordered to refund money to almost 600,000 New Yorkers who were charged too much for health insurance.
Amylin Pharmaceuticals Inc. and Eli Lilly and Co. have agreed to end a decade-long diabetes partnership to resolve litigation. Amylin will make an upfront payment of $250 million to Lilly and future revenue-sharing payments of $1.2 billion plus interest.
Eli Lilly and Co. and Bristol-Myers Squibb Co. won U.S. approval to expand marketing of the cancer drug Erbitux for late-stage head and neck tumors.
Trinity Free Clinic in Carmel began in 2000 to serve a growing Hispanic immigrant population. Since the latest recession, so many people—including unemployed professionals—have found their way to the clinic that the portion of white patients has grown from one-third in 2008 to 47 percent last year.
Eli Lilly and Co. hid the diabetes risks of Zyprexa to protect sales, a lawyer for the family of a 20-year-old patient who died while taking the medicine told a jury in the first case to go to trial over the drug. The attorney asked jurors to award the family $40 million in compensatory damages.
The British Supreme Court ruled in favor of Human Genome Sciences Inc. in its dispute with Eli Lilly and Co. over the validity of a patent for a gene sequence that could be used to treat people with immune diseases.
Health-club chain plans to keep six local locations open, but refer members of closed locations to LA Fitness.